GonzalezEA,SachdevaA,OliverDA,MartinKJ, 2004.Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study,Am J Nephrol 24 503 -10
BhanI,Bumett-BowieSA,YeJ,TonelliM,ThadhaniR., 2010.Clinical measures identify vitamin D deficiency in dialysis,Clin J Am Soc Nephrol 5 460 -7
Roj,-RiveraJ,De La PiedraC,RamosA,OrtizA,EgidoJ, 2010.,The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant 25 2850 -65
DussoAS,TokumotoM., 2011.Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease,Kidney Int 79 715 -29
PilzS,TomaschitzA,FriedlC,AmreinK,DrechslerC,RitzE, 2011.Vitamin D status and mortality in chronic kidney disease,Nephrol Dial Transplant 26 3603 -9
GuillotX,SemeranoL,Saidenberg-Kermanac'h N,FalgaroneG,BoissierMC, 2010.Vitamin D and inflammation,Joint Bone Spine 77 552 -7
HewisonM., 2010.Vitamin D and the immune system: new perspectives on an old theme,Endocrinol Metab Clin North Am 39 365 -79
TimmsPM,MannanN,HitmanGA,NoonanK,MillsPG,Syndercombe-CourtD, 2002.Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype; mechanisms for inflammatory damage in chronic disorders,QJM 95 787 -96
AmerM,QayyumR,HydoxyvitaminD,C-, 2012.Reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001 to,Am J Cardiol 109 226 -30
BertoldoF,PancheriS,ZenariS,BoldiniS,GiovanazziB,ZanattaM, 2010.Serum 2S-hydroxyvitamin D levels modulate the acute phase response associated with the first nitorogen-containing bisphosphonate infusion,J Bone Miner Res 25 447 -54
ScharlaSH,Scheidt-NaveC,LeidigG,WoitgeH,WusterC,Seibel MJ, 1996.Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study,Exp Clin Endocrinal Diabetes 104 289 -92
EdaS,RoosW, 1998.Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range,J Clin Lab Anal 12 137 -44
HackengWH,LipsP,NetelenbosJC,LipsCJ, 1986.Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients,J Clin Endocrino Metab 63 447 -53
AdamsPC,ReboussinDM,PressRD,BartonJC,ActonRT,MosesGC, 2007.Biological variability of transferrin saturation and unsaturated iron-binding capacity,Am J Med 120 999 -
KandulaP,DobreM,ScholdJD,Schreiber MJ,MchrotraR,NavaneethanSD, 2011.Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials,Clin J Am Soc Nephrol 6 50 -62
DarouxM,ShenoudaM,BacriJL,LemaitreV,VanhilleP,BatailleP.,Vitamin, 2013.D2 versus vitamin D3 supplementation in hemodialysis patients; a comparative pilot study,J Nephrol 26 152 -7
IzquierdoMJ,CaviaM,MuñizP,de FranciscoAL,AriasM,SantosJ, 2012.Paricalcitol reduces oxidative stress and inflammation in haemodialysis patients,BMC Nephrol 13 159 -
LevinA,BakrisGL,MolitchM,SmuldersM,TianJ,WilliamsLA, 2007.Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease; results of the study to evaluate early kidney disease,Kidney Int 71 31 -8
Borrego UtielFJ,Bravo SotoJA,Merino PérezMJ,González CarmeloI,López JiménezV,García ÁlvarezT, 2015.Effect of paricalcitol on mineral metabolism in kidney transplant patients with secondary hyperparathyroidism,Nefrologia 35 363 -73
KorkorAB, 1987.-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure,N Engl J Med 316 1573 -7
Večerić-HalerŽ,RomoziK,AntoničM,BenedikM,PonikvarJB,PonikvarR, 2016.Comparison of the pharmacological effects of paricalcitol versus calcitriol on secondary hyperparathyroidism in the dialysis population,Ther Apher Dial 20 261 -6
KatesDM,SherrardDJ,AndressDL, 1997.Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure,Am J Kidney Dis 30 809 -13
YamamotoM,IgarashiT,MuramatsuM,FukagawaM,MotokuraT,OgataE, 1989.Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat,J Clin Invest 83 1053 -6
LlachF,MassrySG,SingerFR,KurokawaK,KayeJH,CoburnJW, 1975.Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism,J Clin Endocrinol Metab 41 339 -45
FukagawaM,KazamaJJ, .Its role in renal bone disease, -
2006.,Pediatr Nephrol 21 1802 -6
KazamaJJ,GejyoF,ShigematsuT,FukagawaM., 2005.Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism,Ther Apher Dial 9 328 -30
KramerH,BemsJS,ChoiMJ,MartinK,RoccoMV,HydroxyvitaminD testing, 2014.and supplementation in CKD: an NKFKDOQI controversies report,Am J Kidney Dis 64 499 -509
2010.Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters,Clin J Am Soc Nephrol 5 905 -11
MoraJR,IwataM, 2008.Vitamin effects on the immune system; vitamins A and D take centre stage,Nat Rev Immunol 8 685 -98
CantornaMT,ZhuY,FroicuM,WittkeA,-dihydroxyvitaminD3, 2004.and the immune system,Am J Clin Nutr 80 1717 -20
MatilainenJM,HussoT,ToropainenS,SeuterS,TurunenMP,GyntherP, 1803.Primary effect of 1α, 25(OH)2D3 on IL-10 expression in monocytes is short-term downregulation,Biochem Biophys Acta 1276 -86
AdoriniL,PennaG,FibbiB,MaggiM. Vitamin, 2010.D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia,Ann N Y Acad Sci 1193 146 -52
HanT,RongG,QuanD,ShuY,LiangZ,SheN, 2013.Metaanalysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease,Biomed Res Int 320560 -
Vitamin, 2013.D supplementation affects serum high-sensitivity Creactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women,J Nutr 143 1432 -8
Blanco-RojoR,Pdrez-GranadosAM,ToxquiL,ZazoP,de la PiedraC,VaqueroMP, 2013.Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food,Eur J Nutr 52 695 -703
NormanAW, 2006.Minireview: vitamin D receptor: new assignments for an already busy receptor,Endocrinol 147 5542 -8
GoicoecheaM,VazquezMI,RuizMA,Gomez-CampderaF,Perez-GarciaR, 1998.Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients,Nephron 78 23 -7
KumarVA,KujubuDA,SimJJ,RasgonSA,YangPS, 2011.Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients,J Nephrol 24 98 -105